510(k) Report

510(k) · Cleared

Cleared

Atellica® CH Creatinine_3 (Crea3)

K242685510(k) TraditionalCleared Dec 4, 202489-day reviewClass II21 CFR 862.1225

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Siemens Healthcare Diagnostics, Inc. · CGX Alkaline Picrate, Colorimetry, Creatinine

Cleared on Dec 4, 2024 as substantially equivalent to K161494 (Siemens Healthcare Diagnostics, Inc., 2016) after an 89-day review. Its family tree reaches back 3 generations to 1998. 1 later device descends from it.

Decided
Dec 4, 2024
Review
89 days
Class
Class II
Product code
CGX
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K973993 (1998). 5 ancestors in all. 1 later device descends from it, 1 citing it directly.

  1. Root · 3 generations backK973993 Randox CreatinineRandox Laboratories, Ltd. · 1998
  2. 2 generations backK070727 Advia Chemistry Enzymatic Creatinine_2Siemens Medical Solutions Diagnostics · 2007 · Recalled
  3. 1 generation backK161494 Atellica CH Creatinine_2 (Crea_2), Atellica CH Chemistry Calibrator…Siemens Healthcare Diagnostics, Inc. · 2016 · Recalled
  4. This deviceK242685 Atellica® CH Creatinine_3 (Crea3)Siemens Healthcare Diagnostics, Inc. · 2024
  5. Descendant · cites it directly · 0 of its ownK251058 Tru Kidney Health Test Panel; Tru AnalyzerTruvian Health · 2025

Most influential descendants

Showing 1 of 1 · See all
  • K251058Tru Kidney Health Test Panel; Tru AnalyzerTruvian Health · 2025 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K973993Randox CreatinineRandox Laboratories, Ltd.1998—
−2K070727Advia Chemistry Enzymatic Creatinine_2Siemens Medical Solutions Diagnostics20075
−1K161494Atellica CH Creatinine_2 (Crea_2), Atellica CH Chemistry Calibrator (CHEM CAL)Siemens Healthcare Diagnostics, Inc.20161
0 (this device)K242685Atellica® CH Creatinine_3 (Crea3)Siemens Healthcare Diagnostics, Inc.2024—
+1K251058Tru Kidney Health Test Panel; Tru AnalyzerTruvian Health2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199910
200510

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202510
FIG. 1 — Lineage of K242685, 1998–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CGX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CGX device

  1. #1 K221813 Nova Allegro UACR Assay, Nova Allegro Analyzerscore 11.7 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K161494Atellica CH Creatinine_2 (Crea_2), Atellica CH Chemistry Calibrator (CHEM CAL)
Summary page 5
…ate Device Predicate Device Predicate 510(k) Clearance# Atellica® CH Creatinine_3 Atellica® CH Creatinine_2 K161494 (Crea3) (Crea_2) Siemens Healthcare Diagnostics Inc.…
Siemens Healthcare Diagnostics, Inc.20161

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K251058Tru Kidney Health Test Panel; Tru AnalyzerTruvian Health20250

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 26 years and passes through 3 companies; a new generation was cleared every 9.3 years on median.
  • 4 of the 5 ancestors have a recall of any class.
  • Of its descendants, K251058 (Truvian Health, 2025) has gone furthest, with 0 descendants of its own.

How does its category compare?

All CGX devices

CGX Alkaline Picrate, Colorimetry, Creatinine: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · CGX

1in 2025

2007: 42009: 12012: 12013: 12014: 22016: 12022: 12024: 22025: 12026 (partial year): 1
2007high 4 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CGX

25in 2007

2007: 25 days median
2007high 25 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CGX

2in 2016

2008: 12009: 22010: 22011: 12012: 22016: 22026 (partial year): 1
2007high 2 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CGX

34in 2025

2007: 152008: 272009: 52010: 52011: 322012: 132013: 242014: 132015: 132016: 32017: 212018: 142019: 252020: 192021: 132022: 232023: 192024: 322025: 34
2007high 34 (2025) · low 3 (2016)2025

MAUDE reports naming product code CGX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007425015
20080—127
20091—25
20100—25
20110—132
20121—213
20131—024
20142—013
20150—013
20161—23
20170—021
20180—014
20190—025
20200—019
20210—013
20221—023
20230—019
20242—032
20251—034
20261—1—

What is it indicated for?

The Atellica® CH Creatinine_3 (Crea3) assay is for in vitro diagnostic use in the quantitative determination of creatinine in human serum, plasma (lithium heparin, dipotassium EDTA, and sodium heparin), and urine using the Atellica® CH Analyzer. Such measurements are used in the diagnosis and treatment of renal diseases, and in monitoring renal dialysis.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K242685: Atellica® CH Creatinine_3 (Crea3).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K242685

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026